Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
2.
Health Equity ; 4(1): 382-385, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32964175

RESUMEN

Purpose: To assess the trends and sociodemographic disparities of anal cancer. Methods: For this time series, billing claims were reviewed for all encounters between 2007 and 2011 in the Yale New Haven Health System. Results: There were 80 new cases identified. Decreasing trends were seen in women and increasing trend in men (-30.1% and 27.3%). Diagnoses were more common in areas with the highest proportion of racial minorities (incidence rate ratio [IRR]=1.75; p≤0.01) and poverty (IRR=1.72; p=0.04). Conclusions: Anal cancer continues to rise in men during the postvaccine era. Communities with the highest proportion of poverty and racial/ethnic minority groups bear the highest burden of disease.

5.
Laeknabladid ; 100(2): 75-82, 2014 02.
Artículo en Islandés | MEDLINE | ID: mdl-24639430

RESUMEN

Colorectal cancer is the third most common cancer in the Western hemisphere and the incidence increases with increasing age. Most colorectal cancers are localized with or without lymph node metastases. Up to 20% of patients present with metastatic disease, most commonly to the liver. Surgery is the only curative therapy for localized colorectal cancer and adjuvant chemotherapy is usually recommended for patients with lymph node metastases. Surgery, radiation therapy and chemotherapy are the key components of rectal cancer therapy. Selected patients with recurrent and metastatic disease can be salvaged with surgery but chemotherapy remains the mainstay of therapy for advanced colorectal cancer. Substantial progress has been observed in the treatment of metastatic colorectal cancer in recent years.


Asunto(s)
Neoplasias Colorrectales , Factores de Edad , Neoplasias Colorrectales/diagnóstico , Neoplasias Colorrectales/epidemiología , Neoplasias Colorrectales/terapia , Terapia Combinada , Humanos , Incidencia , Factores de Riesgo , Resultado del Tratamiento
6.
Scand J Infect Dis ; 34(10): 778-80, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12477337

RESUMEN

A 30-y-old man with Crohn's disease developed fungemia with Candida albicans. Subsequently, during therapy with fluconazole, Candida glabrata was repeatedly isolated from his blood. Myocardial abscesses were detected in the papillary muscles and interventricular septum. The infection was cured with amphotericin B lipid complex and 5-flucytosine, followed by voriconazole for 18 months.


Asunto(s)
Antifúngicos/administración & dosificación , Candida glabrata/aislamiento & purificación , Candidiasis/tratamiento farmacológico , Fungemia/tratamiento farmacológico , Miocarditis/tratamiento farmacológico , Miocarditis/microbiología , Pirimidinas/administración & dosificación , Triazoles/administración & dosificación , Adulto , Candidiasis/diagnóstico , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Ecocardiografía Transesofágica , Estudios de Seguimiento , Fungemia/diagnóstico , Humanos , Masculino , Miocarditis/diagnóstico por imagen , Índice de Severidad de la Enfermedad , Tomografía Computarizada por Rayos X , Resultado del Tratamiento , Voriconazol
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...